Joseph J. Larosa - 09 Sep 2022 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP General Counsel and Secret
Signature
/s/**Joseph LaRosa
Issuer symbol
REGN
Transactions as of
09 Sep 2022
Net transactions value
-$7,039,901
Form type
4
Filing time
12 Sep 2022, 16:30:29 UTC
Previous filing
11 Apr 2022
Next filing
13 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $8,112,900 +30,000 +259% $270.43 41,580 09 Sep 2022 Direct
transaction REGN Common Stock Tax liability $15,152,801 -20,730 -50% $730.96 20,850 09 Sep 2022 Direct
holding REGN Common Stock 2,109 09 Sep 2022 2021 GRAT
holding REGN Common Stock 5,320 09 Sep 2022 2022 GRAT
holding REGN Common Stock 335 09 Sep 2022 By 401(k) Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -30,000 -75% $0.000000 10,000 09 Sep 2022 Common Stock 30,000 $270.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option award vests in four equal annual installments, commencing one year after the date of grant.